BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 4 filers reported holding BIOCRYST PHARMACEUTICALS in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $49,000 | – | 16,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 613 | $446,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 163,400 | $1,190,000 | 0.02% |
| Citadel Advisors | 53,300 | $388,000 | 0.00% |